MMCAP International’s Tevogen Inc. Common Stock TVGN Stock Holding History

MMCAP International’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,000	Closed	-$8.26M	–	277
2022 Q4	$8.26M	Hold	16,000	–	–	0.84%	31
2022 Q3	$8.12M	Hold	16,000	–	–	0.64%	39
2022 Q2	$8.01M	Sell	16,000 -10,000	-38%	-$5.01M	0.64%	38
2022 Q1	$13M	Buy	+26,000	New	+$12.9M	0.76%	21

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MMCAP International's TVGN Position: Q1 2023 in Review

MMCAP International sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 16,000 shares — an estimated $8.26M sold.

MMCAP International first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $13M in Q1 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

MMCAP International reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
MMCAP International sold 16,000 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $8.26M.
MMCAP International first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
MMCAP International's Tevogen Inc. Common Stock position peaked at $13M in Q1 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on MMCAP International's 13F filing for Q1 2023, filed 11 May 2023.